XBIO — Xenetic Biosciences Share News
0.000.00%
Last trade - 00:00- $4.03m
- -$2.44m
- $2.98m
Brief: Xenetic Biosciences Inc Reports First Quarter 2023 Financial Results And Provides Business Update
Xenetic Biosciences Inc expected to post a loss of 11 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Hyzon Motors, TG Therapeutics, Newmont
Brief: Xenetic Biosciences Inc Reports Quarterly Loss Of $0.8 MILLION
Brief: Xenetic Biosciences Reports Q2 2022 Financial Results
Xenetic Biosciences rises on licensing agreement
Brief: Xenetic Biosciences Inc - On April 26, Co Entered Exclusive Sublicense Agreement With CLS Therapeutics
Brief: Xenetic Biosciences Enters At The Market Offering Agreement Relating To The Offer And Sale Of Up To $4 Mln Of Shares
Brief: Xenetic Biosciences Amended Agreement With Pharmsynthez To Terminate All Agreement Work Orders
Brief: Xenetic Biosciences Files For Mixed Shelf Of Up To $50 Million
Brief: Xenetic Biosciences Files Prelim Prospectus Related To Resale Of Up To 950,000 Shares Issued To The Selling Stockholder - SEC Filing
U.S. STOCKS ON THE MOVE-Aon, Dish Network, ThredUp, PerkinElmer
U.S. STOCKS ON THE MOVE-Tyme, Owlet, Lockheed Martin, ATI Physical Therapy
Xenetic Biosciences jumps again after $12.5 mln share placement
Xenetic Biosciences Inc reports results for the quarter ended in March - Earnings Summary
Brief: Xenetic Biosciences Reports Net Loss Of $1.3 Mln For Quarter Ended March 31
U.S. STOCKS ON THE MOVE-Facebook, Disney, CureVac, Chevron
U.S. STOCKS ON THE MOVE-CureVac, railroad operators, oil cos, Best Buy
U.S. STOCKS ON THE MOVE-Oncternal, Xenetic, Qiwi, Immutep